The Q2 2019 issue of Morgan Lewis’s Life Sciences International Review was recently released. The review includes updates relevant to the life sciences industry from across the world, including the United States, Europe, and Asia. The topics range from intellectual property and data privacy to international trade and labor and employment. We found it to be an excellent read for anyone interested in keeping up with current trends in the life sciences sector.
Two of the topics that we found to be of particular interest were about data privacy in the European Union and foreign investments in the United States biotechnology industry. The review looks at the opinion adopted by the European Data Protection Board (EDPB) regarding the interplay between the General Data Protection Regulation and the forthcoming Clinical Trials Regulation. The review also discusses the increased activity by the Committee on Foreign Investment in the United States (CFIUS) in scrutinizing life sciences transactions, which has led to several transactions being blocked or mitigated.
The Life Sciences International Review is a quarterly newsletter published by Morgan Lewis lawyers with important updates and insights for the life sciences sector. Be sure to look for the next publication coming in the fall!